{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T09:41:06Z","timestamp":1792575666707,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T00:00:00Z","timestamp":1792108800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.tranon.2026.103083","type":"journal-article","created":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:23:50Z","timestamp":1792563830000},"page":"103083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiovascular disease-specific mortality after partial versus radical nephrectomy for stage II renal cancer: A SEER-based propensity-matched analysis"],"prefix":"10.1016","volume":"74","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4244-034X","authenticated-orcid":false,"given":"Yao","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0592-8886","authenticated-orcid":false,"given":"Zhicheng","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.tranon.2026.103083_bib0002","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0003","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103083_bib0004","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","article-title":"Epidemiology of renal cell carcinoma: 2022 update","volume":"82","author":"Bukavina","year":"2022","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103083_bib0005","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.eururo.2013.06.044","article-title":"Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904","volume":"65","author":"Scosyrev","year":"2014","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103083_bib0006","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.eururo.2013.03.052","article-title":"Three-year oncologic and renal functional outcomes after robot-assisted partial nephrectomy","volume":"64","author":"Khalifeh","year":"2013","journal-title":"Eur. Urol."},{"issue":"13","key":"10.1016\/j.tranon.2026.103083_bib0007","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0008","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5334\/gh.1366","article-title":"Causal links between renal function and cardiac structure, function, and disease risk","volume":"19","author":"Zhou","year":"2024","journal-title":"Glob. Heart"},{"issue":"11","key":"10.1016\/j.tranon.2026.103083_bib0009","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3390\/genes16111303","article-title":"Genomics and Multi-omics perspectives on the pathogenesis of cardiorenal syndrome","volume":"16","author":"Ang","year":"2025","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40620-020-00842-w","article-title":"Renal dysfunction in cardiovascular diseases and its consequences","volume":"34","author":"Deferrari","year":"2021","journal-title":"J. Nephrol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103083_bib0011","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2025.02.020","article-title":"European Association of Urology Guidelines on renal cell Carcinoma: the 2025 update","volume":"87","author":"Bex","year":"2025","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0012","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.eururo.2014.09.027","article-title":"Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function","volume":"67","author":"Capitanio","year":"2015","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0013","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.eururo.2016.08.060","article-title":"Partial nephrectomy versus radical nephrectomy for clinical T1b and T2 renal tumors: a systematic review and meta-analysis of comparative studies","volume":"71","author":"Mir","year":"2017","journal-title":"Eur. Urol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103083_bib0014","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.eururo.2018.05.004","article-title":"Outcomes of robot-assisted partial nephrectomy for clinical T2 renal tumors: a multicenter analysis (ROSULA Collaborative Group)","volume":"74","author":"Bertolo","year":"2018","journal-title":"Eur. Urol."},{"issue":"11","key":"10.1016\/j.tranon.2026.103083_bib0015","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/iju.14664","article-title":"Partial versus radical nephrectomy in clinical T2 renal masses","volume":"28","author":"Klett","year":"2021","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.tranon.2026.103083_bib0016","article-title":"Partial nephrectomy versus radical nephrectomy for clinical T2 or higher stage renal tumors: a systematic review and meta-analysis","volume":"11","author":"Huang","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.tranon.2026.103083_bib0017","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.3390\/cancers15102782","article-title":"Survival in kidney and bladder cancers in four Nordic countries through a half century","volume":"15","author":"Tichanek","year":"2023","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0018","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.eururo.2025.06.005","article-title":"Epidemiology of renal cancer: incidence, mortality, survival, genetic predisposition, and risk factors","volume":"88","author":"Larcher","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tranon.2026.103083_bib0019","article-title":"Cause-specific mortality among survivors from T1N0M0 renal cell carcinoma: a registry-based cohort study","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103083_bib0020","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jaccao.2025.06.004","article-title":"Longitudinal patterns of cardiovascular disease and cancer mortality in renal cell carcinoma patients by tumor stage","volume":"7","author":"Deng","year":"2025","journal-title":"JACC CardioOncology"},{"key":"10.1016\/j.tranon.2026.103083_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2025.102758","article-title":"Trend of cardiovascular mortality among metastatic renal cell cancer patients in the US from 2005 to 2020","volume":"95","author":"Baral","year":"2025","journal-title":"Cancer Epidemiol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0022","doi-asserted-by":"crossref","DOI":"10.31083\/RCM25277","article-title":"Cardiovascular disease and other competing causes of death in older kidney cancer patients","volume":"26","author":"Liang","year":"2025","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.tranon.2026.103083_bib0023","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.564631","article-title":"Comparison of T2N0M0 and T3aN0M0 in predicting the prognosis of patients with renal cell carcinoma","volume":"10","author":"He","year":"2020","journal-title":"Front Oncol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0024","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.euo.2018.08.023","article-title":"Clinical stage migration and survival for renal cell carcinoma in the United States","volume":"2","author":"Patel","year":"2019","journal-title":"Europ. Urol. Oncol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2019.08.011","article-title":"Stage-specific conditional survival in renal cell carcinoma after nephrectomy","volume":"38","author":"Cheaib","year":"2020","journal-title":"Urol. Oncol."},{"issue":"2","key":"10.1016\/j.tranon.2026.103083_bib0026","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0302-2838(01)00027-6","article-title":"Prognostic factors in patients with renal cell carcinoma: retrospective analysis of 675 cases","volume":"41","author":"Ficarra","year":"2002","journal-title":"Eur. Urol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0027","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.eururo.2025.01.014","article-title":"Updated European Association of Urology guidelines on the use of adjuvant immune checkpoint inhibitors and subsequent therapy for renal cell carcinoma","volume":"87","author":"Bedke","year":"2025","journal-title":"Eur. Urol."},{"key":"10.1016\/j.tranon.2026.103083_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2024.1370702","article-title":"Time trends in surgical provision and cancer-specific outcomes in patients with stage T2-3 kidney cancer: a SEER-based study","volume":"11","author":"Song","year":"2024","journal-title":"Front. Surg."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0029","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/bju.15064","article-title":"Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) collaborative group","volume":"126","author":"Bradshaw","year":"2020","journal-title":"BJU Int."},{"issue":"3","key":"10.1016\/j.tranon.2026.103083_bib0030","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/JU.0000000000000326","article-title":"Chronic kidney disease and kidney cancer surgery: new perspectives","volume":"203","author":"Huang","year":"2020","journal-title":"J. Urol."},{"issue":"4","key":"10.1016\/j.tranon.2026.103083_bib0031","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.juro.2014.04.016","article-title":"Chronic kidney disease due to surgical removal of nephrons: relative rates of progression and survival","volume":"192","author":"Demirjian","year":"2014","journal-title":"J. Urol."},{"issue":"5","key":"10.1016\/j.tranon.2026.103083_bib0032","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.juro.2012.11.121","article-title":"Surgically induced chronic kidney disease may be associated with a lower risk of progression and mortality than medical chronic kidney disease","volume":"189","author":"Lane","year":"2013","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.tranon.2026.103083_bib0033","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.eururo.2015.04.043","article-title":"Survival and functional stability in chronic kidney disease due to surgical removal of nephrons: importance of the new baseline glomerular filtration rate","volume":"68","author":"Lane","year":"2015","journal-title":"Eur. Urol."},{"issue":"1","key":"10.1016\/j.tranon.2026.103083_bib0034","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/bju.13994","article-title":"Analysis of survival for patients with chronic kidney disease primarily related to renal cancer surgery","volume":"121","author":"Wu","year":"2018","journal-title":"BJU Int."},{"key":"10.1016\/j.tranon.2026.103083_bib0035","article-title":"Molecular landscape and clinical translation of DNA damage response alterations in solid tumors: a pan-cancer perspective on precision oncology","volume":"77","author":"Zhu","year":"2026","journal-title":"Neoplasia (N. Y. NY)"},{"key":"10.1016\/j.tranon.2026.103083_bib0036","article-title":"LOXL2\u207a cancer-associated fibroblasts shape WNT signaling to drive chemoresistance and poor outcomes in colorectal cancer: insights from multi-omics and epidemiological analyses","volume":"72","author":"Xu","year":"2026","journal-title":"Neoplasia (N. Y. NY)"},{"key":"10.1016\/j.tranon.2026.103083_bib0037","article-title":"Multi-omics analysis unveils tumor heterogeneity and immunotherapy predictive model in breast cancer for precision medicine and early detection","volume":"71","author":"Zhao","year":"2026","journal-title":"Neoplasia (N. Y. NY)"}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326004195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:52:47Z","timestamp":1792572767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326004195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":37,"alternative-id":["S1936523326004195"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103083","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease-specific mortality after partial versus radical nephrectomy for stage II renal cancer: A SEER-based propensity-matched analysis","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.103083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"103083"}}